Press Releases

Sep

24

Cytosurge and Lexogen Announce First End-to-End Commercial Live-Cell Sequencing Workflow

by Erica Fiorini | September 24, 2025

664

Zürich, Switzerland, and Vienna, Austria – Sept. 24, 2025 – Cytosurge AG, a leader in single-cell manipulation technologies, and Lexogen, a pioneer in RNA sequencing solutions, today announced that th... Read more >

Press Release

Erica Fiorini

Apr

09

Cytosurge Appoints Magid Haddouchi as Chief Commercial Officer

by Erica Fiorini | April 9, 2025

3236

Zurich, Switzerland – April 9, 2025 – Cytosurge AG, a leading biotech company in single-cell manipulation and cell engineering solutions, announces the appointment of Magid Haddouchi, PhD, as its new ... Read more >

Press Release

Erica Fiorini

Jan

09

Cytosurge Announces Strategic Leadership Transition

by Erica Fiorini | January 9, 2025

4013

Zürich, Switzerland – January 9, 2025 – Cytosurge AG, a leader in single-cell manipulation, a biotech company pioneering innovative single-cell biopsies and cell-line engineering solutions, announces ... Read more >

Press Release

Erica Fiorini

Oct

15

Cytosurge and Lexogen Partner to Advance Live-Cell Sequencing

by Erica Fiorini | October 15, 2024

5030

Zürich, Switzerland, and Vienna, Austria – October 15, 2024 – Cytosurge AG, a leader in single-cell manipulation, and Lexogen, a pioneer in RNA sequencing solutions, have announced their partnership... Read more >

Press Release

Erica Fiorini

May

29

Cytosurge’s CellEDIT Workflow, based on its Proprietary FluidFM® Technology, Receives Validation in Peer-Reviewed Publication

by Erica Fiorini | May 29, 2024

6200

CellEDIT Service represents a novel workflow leveraging FluidFM-mediated intranuclear nanoinjection of CRISPR/Cas9 components into single cells. Control of the amount and stoichiometry of RNP complexe... Read more >

Press Release

Corporate FluidFM Applications

ERS Genomics

Jun

28

New CRISPR/Cas9 license agreement for ERS Genomics and Cytosurge

by ERS Genomics | June 28, 2022

8235

Dublin, Ireland | ERS Genomics Limited (‘ERS’) is pleased to announce a new license agreement with Cytosurge AG (‘Cytosurge‘). This is a non-exclusive licensing agreement granting Cytosurge access to ... Read more >

Press Release

Corporate FluidFM Applications

Stony Brook University (SUNY)

Jun

22

Research Centered on Single Cells May Open Doors to New Discoveries on Disease Processes

by Stony Brook University (SUNY) | June 22, 2022

3231

Stony Brook, NY | Gábor Balázsi , PhD, and his research team in the Laufer Center and the Department of Biomedical Engineering at Stony Brook University are embarking upon a new way to research cells,... Read more >

Press Release

Corporate FluidFM Applications

Claudia Frey

Mar

30

Cytosurge launches cell line engineering services based on proprietary FluidFM® technology

by Claudia Frey | March 30, 2022

7768

Zurich | Genetically engineered cell lines have become an invaluable tool in biological research and drug discovery. Nobel-prize winning CRISPR technology has opened up multiple opportunities for gene... Read more >

Press Release

Corporate FluidFM Applications

Claudia Frey

Jan

18

R&D project by Cytosurge and the Laboratory of Biosensors and Bioelectronics at the Swiss Federal Institute of Technology receives funding by Innosuisse

by Claudia Frey | January 18, 2022

7665

Zurich | Cytosurge , a leading global provider for precision single cell manipulation, is delighted to announce that together with the Laboratory of Biosensors and Bioelectronics (LBB) at the Swiss Fe... Read more >

Press Release

Corporate FluidFM Applications

Claudia Frey

Aug

04

Partnership between Central Scientific Commerce and Cytosurge

by Claudia Frey | August 4, 2021

7858

Zurich | We are delighted to announce our collaboration with CSC, a well-established and renowned Japanese organization specialized in the distribution of systems for life science research. Within thi... Read more >

Press Release

Corporate

Claudia Frey

Mar

24

Cytosurge’s FluidFM Technology Facilitates Multiplex CRISPR Editing and Monoclonal Cell Line Development in less than Three Weeks

by Claudia Frey | March 24, 2021

7627

Zurich | Cytosurge , a leading global provider for precision single cell manipulation , announced today that its pioneering, patented FluidFM nano-probe enabled CRISPR multiplexing to generate monoclo... Read more >

Press Release

Corporate FluidFM Applications

Claudia Frey

Jul

23

Olympus and Cytosurge collaborate to deliver a complete single-cell and CRISPR genetic manipulation solution in the Americas

by Claudia Frey | July 23, 2020

9100

Waltham, Mass. & Zurich | Olympus , a leading manufacturer of high-end research microscopes, and Cytosurge , a precision manufacturer of cell manipulation technologies, have entered a co-marketing agr... Read more >

Press Release

Corporate

Stay up to date with our news.

About us

Archives

News

Tags

Follow us